Wed, January 10, 2018

Exicure, Inc. announced the closing of approximately $11.2 million in subsequent financing led by Luye Pharma Group and others including Eager Info Investments LTD, Knoll Capital Management and Purple Arch Ventures. With this investment, the company has raised a total of approximately $31.5 million in this current round.

"Nucleic acid therapeutics hold great promise because they target the underlying genetic source of disease," said Dr. David Giljohann, Chief Executive Officer of Exicure. "Toxicity and delivery have been the primary challenges for companies seeking to use nucleic acids in drug development. Our SNA technology seeks to overcome these challenges and to change the cost curves and development timelines of highly targeted medicines. We are advancing a pipeline of drugs for a broad range of chronic conditions and orphan diseases in dermatology, ophthalmology, respiratory and gastric disorders, and solid tumors. We welcome this new round of investors in Exicure as they bring great insight into rapidly emerging markets for our products."

"As we look to the next generation of innovative pharmaceuticals, we clearly see a major role for nucleic acid therapies that regulate genes and enhance the immune system to combat disease," said Dr. Li You Xin, Senior Vice President and head of R&D of Luye Pharma Group. "The team at Exicure has made tremendous strides in unlocking the potential of these highly-targeted medicines."

Tue, August 29, 2017

Versum Materials, Inc., a leading global materials supplier to the semiconductor industry, and NuMat Technologies, a pioneer in the design and integration of atomically-engineered materials into gas delivery, separation and purification systems, announced a global, commercial agreement to offer a new line of products for the safe storage and delivery of high-value gases used in semiconductor manufacturing.

The new product line is called ION-X® and is based on revolutionary Metal Organic Frameworks (MOFs), which can selectively adsorb, store and safely deliver ultrahigh purity gases at sub-atmospheric pressures. "This relationship with Versum represents a strategic pairing of NuMat's differentiated technology platform with Versum's operational, quality and commercial leadership in the semiconductor industry. We look forward to executing against a shared mission of delivering value and innovation to customers," stated Ben Hernandez, Chief Executive Officer at NuMat Technologies. To read the entire press release, click here.


August 2017

NuMat Technologies & Versum Materials

Versum Materials, Inc., a leading global materials supplier to the semiconductor industry, and NuMat Technologies, a pioneer in the design and... Read on >

July 2017

Check out Mid Year SKOKIEBIZ

2017 has brought several new notable rankings for the Village.  ... Read on >

June 2017

Northwestern launches Ronald and JoAnne Willens Center for Nano Oncology

Led by Chad A. Mirkin, George B. Rathmann Professor of Chemistry in the Weinberg College of Arts and Sciences and director of the IIN, the Willens... Read on >

April 2017

Fresenius Kabi to Acquire Akorn

Strategically complementary combination to enhance and diversify Fresenius Kabi’s business and portfolio.  "Joining our two... Read on >